Published

Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: PLoS medicine
Date: 2025-09-01
Source: PubMed
DOI: 10.1371/journal.pmed.1004519
PubMed: 40972137

Authors

Lewis BR Hendrick J Byrne K Odette M Wu C Garland EL

Watch author

Derived topics and classifications

psilocybin Depression Randomized Controlled Trial Observational Study Healthcare Workers Safety Adverse Events Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 5 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model2026-12-01 Psilocybin for Fear of Cancer Recurrence2026-08-01 A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression2026-04-06 Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications2026-04-01 Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.2025-09-01

Related papers

Narrative therapy-assisted psilocybin use for treatment of depressionSeattle Pacific University Research Conference · 2017-01-01 Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological DistressWestern CEDAR (Western Washington University) · 2018-01-01